Back
FibroGen 10K Form
Sell
41
FGEN
FibroGen
Last Price:
0.31
Seasonality Move:
45.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-06 | 10Q | FGEN/FibroGen Quarterly |
2023-08-07 | 10Q | FGEN/FibroGen Quarterly |
2023-05-08 | 10Q | FGEN/FibroGen Quarterly |
2022-11-07 | 10Q | FGEN/FibroGen Quarterly |
2022-08-08 | 10Q | FGEN/FibroGen Quarterly |
2022-05-09 | 10Q | FGEN/FibroGen Quarterly |
Receive FGEN News And Ratings
See the #1 stock for the next 7 days that we like better than FGEN
FGEN Financial Statistics
Sales & Book Value
Annual Sales: | $147.75M |
---|---|
Cash Flow: | $-39.88M |
Price / Cash Flow: | 0 |
Annual Sales: | $-2.31 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -1.71000 |
---|---|
Net Income (TTM): | $-168.32M |
Gross Margin: | $128.9M |
Return on Equity: | 0% |
Return on Assets: | -40.89% |
FibroGen Earnings Forecast
Key FibroGen Financial Ratios
- The Gross Profit Margin over the past 11 years for FGEN is 87.24%.
- The Selling, General & Administrative Expenses for FGEN have been equal to 78.00% of Gross Profit Margin.
- The Research & Development expenses have been 191.44% of Revenue.
- The Interest Expense is -5.46% of Operating Income.
- The Net Earning history of FGEN is -192.37% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
FibroGen Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | FGEN |
CUSIP: | 31572Q |
Website: | fibrogen.com |
Debt
Debt-to-Equity Ratio: | -0.31 |
---|---|
Current Ratio: | 1.41 |
Quick Ratio: | 1.18 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |